Related Experiment Video

Updated: Mar 25, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.4K

The potential for tumor suppressor gene therapy in head and neck cancer

Andrew C Birkeland1, Megan L Ludwig1, Matthew E Spector1

  • 1Department of Otolaryngology - Head and Neck Surgery, University of Michigan Health System, Ann Arbor, MI 48109, USA.

Discovery Medicine
|February 21, 2016
PubMed

Insights

Gene therapy offers a promising approach to restore lost tumor suppressor gene function in head and neck squamous cell carcinoma. Advances in gene editing technology are making this a viable therapeutic strategy for these challenging cancers.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Head and neck squamous cell carcinoma (HNSCC) is a significant cause of cancer-related mortality.
  • Genomic studies reveal frequent mutations in tumor suppressor genes within HNSCC.
  • Current targeted therapies primarily focus on oncogenes, leaving tumor suppressor gene restoration unaddressed.

Purpose of the Study:

  • To review emerging gene therapy techniques for HNSCC.
  • To discuss challenges and future directions for implementing gene therapy in HNSCC.
  • To explore the ethical considerations of gene therapy for HNSCC.

Main Methods:

  • Review of recent scientific literature on gene editing and gene expression modulation.
  • Analysis of advancements in therapeutic strategies for HNSCC.
  • Examination of clinical trial data and research trends in head and neck cancer treatment.

Main Results:

  • Gene editing technologies are rapidly advancing, offering new possibilities for cancer treatment.
  • Restoring lost tumor suppressor gene function presents a novel therapeutic avenue for HNSCC.
  • The review highlights the potential of gene therapy to address a critical unmet need in HNSCC clinical trials.

Conclusions:

  • Gene therapy, particularly utilizing gene editing, holds significant promise for treating HNSCC by targeting tumor suppressor genes.
  • Overcoming implementation challenges and addressing ethical concerns are crucial for the successful translation of gene therapy into clinical practice for HNSCC.
  • Future research should focus on refining gene editing techniques and developing robust clinical strategies for HNSCC gene therapy.

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.4K
In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

7.2K

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

2.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

3.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K